Core Scientific’s largest active shareholder, Two Seas Capital, has publicly opposed the $9 billion acquisition offer by AI infrastructure firm CoreWeave, citing undervaluation and long-term risks.
In a letter released Thursday, the investment firm, which holds a 6.5% stake in Core Scientific, announced its intent to vote against the proposed deal, finalized in July. The letter claims the offer “materially undervalues the Company and unnecessarily exposes its shareholders to substantial economic risk.”
“The transaction decidedly and unfairly favors CoreWeave at the expense of Core Scientific shareholders,” the statement read.
The backlash comes after Core Scientific’s share price dropped by 30% in the days following the deal’s announcement, signaling widespread investor concerns. Despite a short-term rebound, the stock currently trades at $14.38, a modest 3% increase following the release of the shareholder letter.
CoreWeave, valued at over $58.1 billion, has long eyed Core Scientific as a strategic acquisition target. The companies have worked closely, with CoreWeave leasing AI data center capacity from Core Scientific to meet surging demand for training and inference infrastructure.
“Core Scientific is uniquely positioned to meet the growing demand for AI compute and has a clear runway to compound growth for many years,” Two Seas Capital emphasized.
By acquiring Core Scientific, CoreWeave aims to expand its data center footprint rapidly — a key requirement in today’s high-performance computing (HPC) race. However, shareholders argue that Core Scientific’s intrinsic growth potential should not be surrendered at what they consider a discounted price.
“A $9 billion offer grossly undervalues a company leading the charge in energy-efficient HPC infrastructure,” an institutional analyst commented.
Core Scientific currently holds a market cap of $4.3 billion, and the company’s strategic position in the AI and Bitcoin mining crossover space continues to attract institutional interest.
As the shareholder vote approaches, the spotlight remains on how Core Scientific will respond to growing investor resistance — and whether a revised offer may emerge.
Disclaimer
This content is for informational purposes only and does not constitute financial, investment, or legal advice. Cryptocurrency trading involves risk and may result in financial loss.
We use cookies to personalize content and ads, provide social media features, and analyze our traffic. In accordance with GDPR/AVG and EU cookie regulations, data is processed only with your consent. We may share information about your use of our website with our social media, advertising, and analytics partners, and you can manage or withdraw your consent at any time. View more
Cookies settings
Accept
Privacy & Cookie policy
Privacy & Cookies policy
Cookies list
Cookie name
Active
Privacy Policy
At BitxJournal.com, we respect your privacy and are committed to protecting your personal data. This Privacy Policy explains how we collect, process, store, and protect personal information in accordance with the General Data Protection Regulation (GDPR) and AVG (EU privacy legislation).
1. Data Controller
BitxJournal.com acts as the data controller for all personal data processed through this website.
2. Personal Data We Collect
We may collect and process the following categories of data:
Personal Data
Name and email address (when you subscribe to newsletters or contact us)
Technical & Usage Data
IP address, browser type, operating system
Device information
Pages visited, referral sources, and interaction data
This data is collected via cookies, log files, and analytics technologies.
3. Legal Basis for Processing
We process personal data only when a lawful basis exists, including:
Consent – when you explicitly agree (e.g., cookies, newsletter sign-up)
Legitimate interest – to operate, secure, and improve our website
Legal obligation – when required by applicable laws
You may withdraw your consent at any time.
4. Purpose of Data Processing
Your data is processed for the following purposes:
Operating and maintaining the website
Improving content, usability, and performance
Sending newsletters or updates (only with consent)
Analyzing traffic and user behavior
Responding to inquiries or support requests
5. Cookies & Consent Management
We use cookies and similar technologies in compliance with EU Cookie Law.
Non-essential cookies are placed only after explicit user consent
Users may accept, reject, or manage cookie preferences at any time
Consent can be withdrawn without affecting prior lawful processing
Detailed cookie information is available in our Cookie Settings panel.
6. Third-Party Data Processing
We may share limited data with trusted third-party service providers, including:
Analytics providers (e.g., Google Analytics)
Advertising partners (for personalized or non-personalized ads)
These third parties act as data processors and process data only under contractual obligations compliant with GDPR/AVG.
7. International Data Transfers
Where data is transferred outside the European Economic Area (EEA), we ensure appropriate safeguards are in place, such as Standard Contractual Clauses (SCCs) or equivalent legal mechanisms.
8. Data Retention
We retain personal data only for as long as necessary to fulfill the purposes outlined in this policy or as required by law.
9. Data Security
We implement appropriate technical and organizational security measures to protect personal data against unauthorized access, alteration, disclosure, or destruction.
10. Your GDPR Rights
Under GDPR/AVG, you have the right to:
Access your personal data
Rectify inaccurate or incomplete data
Request data erasure (“right to be forgotten”)
Restrict or object to processing
Data portability
Withdraw consent at any time
Lodge a complaint with a supervisory authority
11. Changes to This Privacy Policy
We reserve the right to update this Privacy Policy at any time. Any changes will be posted on this page with a revised effective date.
12. Contact Information
For privacy-related inquiries or GDPR requests, contact:
